Latest Breaking News On - Tersera therapeutics - Page 1 : comparemela.com

G1 Therapeutics stock jumps amid takeover speculation

G1 Therapeutics stock jumps amid takeover speculation
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Klaus-vedfelt-digitalvision
Tersera-therapeutics

AONN+'s ER+ Premenopausal Breast Cancer Journey Pathway Wins PM360 Pharma Choice Award

/PRNewswire/ The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to share that PM360, a leading trade magazine for marketing.

Jordan-henderson
Program-development
Academy-of-oncology-nurse-patient-navigators
Tersera-therapeutics
Oncology-nurse
Patient-navigators
Premenopausal-breast-cancer-journey-pathway
Pharma-choice-award
Variety-silver
Choice-awards
Academy-of-oncology-nurse-amp-patient-navigators

AONN+'S ER+ Premenopausal Breast Cancer Journey Pathway Wins PM360 Pharma Choice Award

AONN+'S ER+ Premenopausal Breast Cancer Journey Pathway Wins PM360 Pharma Choice Award
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Gwen-coverdale
Jordan-henderson
Program-development
Academy-of-oncology-nurse-patient-navigators
Tersera-therapeutics
Oncology-nurse
Patient-navigators
Premenopausal-breast-cancer-journey-pathway
Pharma-choice-award
Variety-silver-winner
Choice-awards

Goserelin Included in Latest NCCN Breast Cancer Guidelines

The NCCN Breast Cancer Panel has included goserelin at 2 dosing schedules as a method for ovarian function suppression in their updated guidelines.

Texas
United-states
Japan
Japanese
Mays-cancer-center
Tersera-therapeutics
National-comprehensive-cancer-network
Breast-cancer-panel
Division-of-hematology
Practice-guidelines
Medical-oncology

Neoadjuvant chemotherapy can eliminate need for regional nodal irradiation in breast cancer

For patients whose breast cancer converted from lymph node-positive to lymph node-negative disease after neoadjuvant chemotherapy, skipping adjuvant regional nodal irradiation (RNI) did not increase the risk of disease recurrence or death five years after surgery, according to results from the NRG Oncology/NSABP B-51/RTOG 1304 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

San-antonio
Texas
United-states
American
Eleftherios-terry-mamounas
Orlando-health-cancer-institute
Biotheranostics-inc
American-association-for-cancer-research
Breast-program
University-of-central-florida
Genentech
Oncology-breast-committee